激活SUR2B/Kir6.1通道扩张肺微动脉的分子机制

doi:10.13459/j.cnki.cjap.2016.03.013

中国应用生理学杂志 ›› 2016, Vol. 32 ›› Issue (3): 238-241.doi: 10.13459/j.cnki.cjap.2016.03.013

激活SUR2B/Kir6.1通道扩张肺微动脉的分子机制

陈筠¹, 王尚¹, 崔文玉², 龙超良¹, 张雁芳¹, 张浩¹, 汪海^1,2

1. 军事医学科学院卫生学环境医学研究所心血管药物研究中心, 北京 100850;
2. 北京赛德维康医药研究院心血管药物研究中心, 北京 100039

收稿日期:2015-10-28 修回日期:2016-01-18 出版日期:2016-05-28 发布日期:2018-06-12
通讯作者: 汪海,Tel:010-66932651;E-mail:wh9588@sina.com E-mail:wh9588@sina.com
基金资助:
军队医药卫生“十二五”重大专项（AWS11J003）；国家973项目（2012CB518200）

Molecular of pulmonary arterioles relaxation through SUR2B/Kir6.1 channel opening

CHEN Jun¹, WANG Shang¹, CUI Wen-yu², LONG Chao-liang¹, ZHANG Yan-fang¹, ZHANG Hao¹, WANG Hai^1,2

1. Cardiovascular Drug Research Center, Institute of Health and Environmental Medicine, Academy of Military Medical Sciences, Beijing 100850;
2. Cardivascular Drug Research Center, Thadweik Academy of Medicine, Beijing 100039, China

Received:2015-10-28 Revised:2016-01-18 Online:2016-05-28 Published:2018-06-12
Supported by:
军队医药卫生“十二五”重大专项（AWS11J003）；国家973项目（2012CB518200）

摘要/Abstract

摘要： 目的：以ATP敏感性钾通道（K_ATP） SUR2B/Kir6.1亚型开放剂埃他卡林（Ipt）为工具药，研究激活SUR2B/Kir6.1通道扩张肺微动脉作用特征，并探讨其可能的分子机制。方法：利用离体微血管压力-直径监测灌流技术，检测Ipt对大鼠四级肺微动脉的舒张效应（n=6~8），观察内皮损伤后或用K_ATP通道拮抗剂格列苯脲（Gli）、环氧合酶（COX）抑制剂吲哚美辛（Indo）、一氧化氮合酶（NOS）抑制剂L-Nω-硝基精氨酸甲酯（L-NAME）预孵后肺微动脉舒张率的变化。结果：Ipt能够扩张肺微动脉，最大舒张率为（60.53±2.08）%。内皮细胞损伤后，Ipt扩张肺微动脉作用明显减弱，最大舒张率为（9.47±1.56）%，与对照组相比存在显著性差异（P<0.01）。预孵Gli、Indo、L-NAME后，最大舒张率分别下降为（17.49±1.47）%、（37.00±3.88）%、（24.91±2.30）%，与对照组相比均存在显著性差异（P<0.01）。结论：其选择性开放K_ATP通道SUR2B/Kir6.1扩张肺微动脉作用具有内皮细胞依赖性，与其促进内皮细胞释放一氧化氮（NO）和前列环素（PGI₂）相关。

关键词: 肺微动脉, 埃他卡林, 内皮细胞, ATP敏感性钾通道, 大鼠

Abstract: Objective:To study the dilatation characteristics of ATP-sensitive potassium channel (K_ATP) SUR2B/Kir6.1 subtype opener iptakalim (Ipt) in pulmonary arterioles, and to explore its possible mechanism. Methods:Vessels pressure-diameter monitoring perfusion technique was used to observe the dilatation effects of Ipt in rats fourth pulmonary arterioles (n=6~8). After the pulmonary arterioles were pre-treated with removing endothelium or pre-incubated with K_ATP channel blocker glibenclamide (Gli), cyclo-oxygenase (COX) inhibitor indomethacin (Indo) and nitric oxide synthase (NOS) inhibitor L-Nω-Nitro-arginine methyl ester(L-NAME), the dilatation effects of Ipt were observed. Results:Pulmonary arterioles could be relaxed by Ipt, the maximal relaxation rate was (60.53±2.08)%. Compaired with control group, the effects of Ipt in endothelium denuded arterioles were significantly decreased, the maximal relaxation rate was (9.47±1.56)% (P<0.01). The maximal relaxation rate were decreased to(17.49±1.47)%,(37.00±3.88)% and(24.91±2.30)% respectively after Gli,Indo,L-NAME were pre-incubated (P<0.01). Conclusion:Pulmonary arterioles can be relaxed by Ipt. The selective activation of K_ATP SUR2B/Kir6.1 subtype by Ipt was involved in its mechanisms. The endothelium-dependently dilatation of Ipt was related to nitric oxide (NO) and prostacyclin (PGI₂) released by endothelial cells.

Key words: pulmonary arterioles, Iptakalim, endothelial cells, ATP-sensitive potassium channel, rats

陈筠, 王尚, 崔文玉, 龙超良, 张雁芳, 张浩, 汪海. 激活SUR2B/Kir6.1通道扩张肺微动脉的分子机制[J]. 中国应用生理学杂志, 2016, 32(3): 238-241.

CHEN Jun, WANG Shang, CUI Wen-yu, LONG Chao-liang, ZHANG Yan-fang, ZHANG Hao, WANG Hai. Molecular of pulmonary arterioles relaxation through SUR2B/Kir6.1 channel opening[J]. CJAP, 2016, 32(3): 238-241.

参考文献

[1] Nelson JL. Pregnancy and microchimerism in autoimmune disease:protector or insurgent[J]. Arthritis Rheum, 2002, 46(2):291-297.
[2] Stevens AM, McDonnell WM, Mullarkey ME, et al. Microchimeric cells in systemic lupus erythematosus:targets or innocent bystanders[J]. Lupus, 2006, 15(11):820-826.
[3] 顾越英. 系统性红斑狼疮诊治指南_草案_[J]. 中华风湿病学杂志, 2003, 7(8):508-513.
[4] Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited[J]. J Am Soc Nephrol, 2004, 15(2):241-250.
[5] Churg J, Bernstein J, Glassock RJ. Renal disease:classification and atals of glomerular disease[M]. 2^ed. New York:Ikagu-Shoin medical publishers, 1995:4-5.
[6] 张玉军, 陈砚凝, 郑书深, 等. HMGB1/SREBP-1参与IFN-γ介导的小鼠肾小球系膜细胞内的脂质沉积[J]. 中国应用生理学杂志, 2013, 19(1):6-10.
[7] Starzl TE, Demetris AJ, Murase N, et al. Cell migration, chimerism, and graft acceptance[J]. Lancet, 1992, 339(8809):1579-1582.
[8] Yunis EJ, Zuniga J, Romero V, et al. Chimerism and tetragametic chimerism in humans:implications in autoimmunity, allorecognition and tolerance[J]. Immunol Res, 2007, 38(1-3):213-236.
[9] Kremer Hovinga IC, Koopmans M, Baelde HJ, et al. Chimerism occurs twice as often in lupus nephritis as in normal kidneys[J]. Arthritis Rheum, 2006, 54(9):2944-2950.
[10] Bianchi DW, Zickwolf GK, Weil GJ, et al. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum[J]. PNAS U S A, 1996, 93(2):705-708
[11] Johnson KL, McAlindon TE, Mulcahy E, et al. Microchimerism in a female patient with systemic lupus erythematosus[J]. Arthritis Rheum, 2001, 44(9):2107-2111.
[12] Kremer Hovinga IC, Koopmans M, Baelde HJ, et al. Tissue chimerism in systemic lupus erythematosus is related to injury[J]. Ann Rheum Dis, 2007, 66(12):1568-1573.
[13] Kremer Hovinga IC, Koopmans M, de Heer E, et al. Chimerism in systemic lupus erythematosus——three hypotheses[J]. Rheumatology, 2007, 46(2):200-208.
[14] Kremer Hovinga IC, Koopmans M, Grootscholten C, et al. Pregnancy, chimerism and lupus nephritis:a multi-centre study[J]. Lupus, 2008, 17(6):541-547.
[15] Ariga H, Ohto H, Busch MP, et al. Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy:implications for noninvasive prenatal diagnosis[J]. Transfusion, 2001, 41(12):1524-1530.

激活SUR2B/Kir6.1通道扩张肺微动脉的分子机制

Molecular of pulmonary arterioles relaxation through SUR2B/Kir6.1 channel opening

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	扈敬, 李法东, 邵小婷, 李思葳, 张欣颖, 赵冰冰, 徐长庆, 魏璨. 精胺对高糖引起的大鼠心肌纤维化的影响及其机制[J]. 中国应用生理学杂志, 2020, 36(3): 193-196.
[2]	朱建忠, 赵灿, 隋月林, 刘媛媛, 乔跃兵. 瘦素对糖尿病大鼠糖脂代谢及炎性因子的影响[J]. 中国应用生理学杂志, 2020, 36(3): 197-201.
[3]	孙晓娟, 冯武龙, 侯娜, 李娜, 姜蔚丽. 有氧运动和白藜芦醇对2型糖尿病大鼠肾脏JAK2及TGF-β1的影响[J]. 中国应用生理学杂志, 2020, 36(3): 202-206.
[4]	石慧, 梁晓珊, 黄丽文, 罗之刚, 谭龙. 一种高尿酸血症大鼠模型诱导方法的改良和效果评价研究[J]. 中国应用生理学杂志, 2020, 36(3): 223-227.
[5]	杨琼, 潘娅, 陈粲, 戴桃李. 阿尼西坦对血管性痴呆大鼠的治疗作用[J]. 中国应用生理学杂志, 2020, 36(3): 232-234.
[6]	韩洁, 刘子怡, 方振, 田蕾, 杨丹凤, 袭著革, 刘晓华. 重复制动应激对雌性大鼠下丘脑-垂体-卵巢轴的影响[J]. 中国应用生理学杂志, 2020, 36(3): 245-249.
[7]	孙景然, 樊祢祢, 张桢, 吴瑾, 韩殿鹏, 白家磊, 杜连群, 房彦军. 有机磷阻燃剂TDCIPP对雌性大鼠甲状腺的潜在毒性作用[J]. 中国应用生理学杂志, 2020, 36(3): 250-254.
[8]	陈宇峰, 董凡赫, 楼云玮, 寿今豪, 张慧婷, 周一超, 严明, 毛红娇, 张云. 补骨脂素对TCP磨损颗粒所致大鼠成骨细胞损伤的干预作用及其机制[J]. 中国应用生理学杂志, 2020, 36(3): 255-260.
[9]	李家卉, 张敏, 付子豪, 李勇枝, 王佳平, 高峰, 董玲. 经皮穿刺抽取大鼠脑脊液方法的改良[J]. 中国应用生理学杂志, 2020, 36(3): 265-267.
[10]	徐昌顺, 孙培, 林春. 改良型大鼠鞘内穿刺置管针及导管末端注药装置在大鼠鞘内置管术中的应用研究[J]. 中国应用生理学杂志, 2020, 36(3): 283-288.
[11]	王凌星, 洪姗燕, 杨美丽, 黄红红. 丁苯酞对睡眠剥夺大鼠额叶小胶质细胞活化的影响^*[J]. 中国应用生理学杂志, 2020, 36(2): 106-110.
[12]	完建永, 张勇, 刘世强, 华田苗, 孙庆艳. 运动对胰岛素抵抗大鼠肝脏BIM信号通路的影响^*[J]. 中国应用生理学杂志, 2020, 36(2): 115-118.
[13]	姚良雪, 韩家鑫, 魏培韵, 侯思博, 何潇剑, 张瑞岭, 杜爱林. 丁苯酞对慢性酒精中毒大鼠海马、杏仁核H₂S/CBS通路及学习记忆能力的影响^*[J]. 中国应用生理学杂志, 2020, 36(2): 138-142.
[14]	窦丽. 游泳训练对高血压大鼠血压及血栓前状态分子的影响^*[J]. 中国应用生理学杂志, 2020, 36(2): 161-164.
[15]	苏艳红, 袁乾坤, 肖蓉, 陈娟, 李强, 张世超. 抗阻训练对增龄大鼠骨骼肌线粒体功能的影响^*[J]. 中国应用生理学杂志, 2020, 36(2): 165-170.